Researchers have developed a new blood test that measures mitochondrial DNA damage as a potential marker for Parkinson’s disease (PD). The study shows the test could aid in diagnosing PD and assessing responses to LRRK2 kinase inhibitors, which may help in reducing mitochondrial damage in PD patients.
Cellular competition determines X chromosome usage in female bodies
A new study published in Nature Genetics by the Lymphoid Development Group at the MRC Laboratory of Medical Sciences has reveals that the contribution of
July 26, 2024